641 related articles for article (PubMed ID: 6146417)
1. Histamine H2-receptor antagonists in the short- and long-term treatment of duodenal ulcer.
Thomas JM; Misiewicz G
Clin Gastroenterol; 1984 May; 13(2):501-41. PubMed ID: 6146417
[No Abstract] [Full Text] [Related]
2. Clinical review of histamine2 receptor antagonists.
Lipsy RJ; Fennerty B; Fagan TC
Arch Intern Med; 1990 Apr; 150(4):745-51. PubMed ID: 1970232
[TBL] [Abstract][Full Text] [Related]
3. [Histamine H2-receptor antagonists as new anti-ulcer agents].
Takemoto T
Nihon Rinsho; 1984 Jan; 42(1):103-13. PubMed ID: 6143835
[No Abstract] [Full Text] [Related]
4. New histamine H2-receptor antagonists.
Domschke S; Domschke W
Hepatogastroenterology; 1980 Jun; 27(3):163-8. PubMed ID: 6109690
[No Abstract] [Full Text] [Related]
5. Ulcer disease of the upper gastrointestinal tract.
Meeroff JC
Hosp Pract (Off Ed); 1984 Oct; 19(10):177-80, 190, 192 passim. PubMed ID: 6148348
[No Abstract] [Full Text] [Related]
6. [Which drug for peptic ulcer?].
Hameeteman W; Tytgat GN
Ned Tijdschr Geneeskd; 1985 Aug; 129(35):1673-6. PubMed ID: 2864643
[No Abstract] [Full Text] [Related]
7. Influence of cigarette smoking on healing and relapse in duodenal ulcer disease.
Korman MG; Hansky J; Eaves ER; Schmidt GT
Gastroenterology; 1983 Oct; 85(4):871-4. PubMed ID: 6136450
[TBL] [Abstract][Full Text] [Related]
8. [Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists].
Hentschel E
Wien Med Wochenschr; 1983; 133(4-5):104-7. PubMed ID: 6134397
[No Abstract] [Full Text] [Related]
9. Bedtime treatment of duodenal ulcer.
Drug Ther Bull; 1985 Dec; 23(24):95-6. PubMed ID: 2866081
[No Abstract] [Full Text] [Related]
10. Pharmacologic options for the control of peptic ulcer disease.
Levine JB
Adv Intern Med; 1984; 30():425-47. PubMed ID: 6152108
[No Abstract] [Full Text] [Related]
11. [Ranitidine in the treatment of duodenal ulcer. Initial clinical experience with 33 patients].
Noya G; Dettori G; Antona C; Niolu P; Muscas A; Marongiu G; Biglioli P
Minerva Med; 1983 Mar; 74(13):691-3. PubMed ID: 6132353
[TBL] [Abstract][Full Text] [Related]
12. [Changes in therapy of duodenal ulcers. The European Gastro-Club 1983 discusses new pathophysiologic and epidemiologic data referring to drug and surgical therapy].
Demling L
Fortschr Med; 1983 Dec; 101(47-48):2195-6. PubMed ID: 6142849
[No Abstract] [Full Text] [Related]
13. H2-receptor antagonists an Helicobacter pylori eradication.
Lamers CB
Scand J Gastroenterol Suppl; 1995; 212():126-7. PubMed ID: 8578225
[TBL] [Abstract][Full Text] [Related]
14. [Acid anti-secretion therapy in gastric and duodenal ulcer].
Lattanzi A
Clin Ter; 1981 Oct; 99(2):187-205. PubMed ID: 6119184
[No Abstract] [Full Text] [Related]
15. Famotidine in the USA: a review of efficacy studies.
Gitnick G
J Int Med Res; 1989; 17 Suppl 1():17A-24A. PubMed ID: 2566539
[TBL] [Abstract][Full Text] [Related]
16. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
Eriksson S; Långström G; Rikner L; Carlsson R; Naesdal J
Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
[TBL] [Abstract][Full Text] [Related]
17. Histamine-2-receptor antagonists and gastric cancer: update and note on latency and covariates.
La Vecchia C; Negri E; Franceschi S; D'Avanzo B
Nutrition; 1992; 8(3):177-81. PubMed ID: 1356031
[TBL] [Abstract][Full Text] [Related]
18. Duodenal and gastric ulcer healing rates: a review.
Legerton CW
Am J Med; 1984 Nov; 77(5B):2-7. PubMed ID: 6095656
[TBL] [Abstract][Full Text] [Related]
19. Effects of three H2-receptor antagonists (cimetidine, famotidine, ranitidine) on serum gastrin level.
Ohsawa T; Hirata W; Higichi S
Int J Clin Pharmacol Res; 2002; 22(2):29-35. PubMed ID: 12503773
[TBL] [Abstract][Full Text] [Related]
20. [Adverse effects of H2 blockaders].
Arabehety AR
Acta Gastroenterol Latinoam; 1980; 10(4):317-23. PubMed ID: 6115533
[No Abstract] [Full Text] [Related]
[Next] [New Search]
